22nd Century Group Inc (NYSEMKT:XXII) Breaks Free From A Restrictive License Agreement

The 22nd Century Group Inc (NYSEMKT:XXII) has made an announcement outlining that it has come to the end of the 2013 Research License and Commercial Option Agreement it held with British American Tobacco (NYSE:BTI). From now henceforth, BAT has been stripped off all its rights to assets of 22nd Century and any intellectual property. This provider is […]

22nd Century Group Inc (NYSEMKT:XXII) Led On By FDA In Regards To The Phase III Clinical Trials

22nd Century Group Inc (NYSEMKT:XXII) has today made a crucial announcement. The provider and Heracles Pharmaceuticals, which happens to be its wholly owned subsidiary on June 20, 2017, attended a meeting with the multi-discipline review team in the Division of Anesthesia, Analgesia, and Addiction Products. The meeting took place at the Center for Drug Evaluation and […]

22nd Century Group Inc (NYSEMKT:XXII) Unveils Its Non-GMO Very Low Nicotine Tobacco

22nd Century Group Inc (NYSEMKT:XXII), which is a plant biotechnology company that majorly focuses on cannabis research and tobacco harm reduction is excited to announce that its project with North Carolina State University has turned out to be a big success. They have come up with several new Very Low Nicotine (VLN) tobacco varieties which […]

22nd Century Group Inc (NYSEMKT:XXII) CEO Joseph Pandolfino Hopes SEC Investigates Misleading Article Author Role

Boston, MA 08/28/2014 (wallstreetpr) – A biotechnology company, 22nd Century Group Inc (NYSEMKT:XXII) had responded to the unusual trading volume following an article by an author who had recommended the stock as Sell. The company had termed the article as misleading and not inaccurate. CEO Responds The company’s Founder and Chief Executive Officer, Joseph Pandolfino, had […]

22nd Century Group Inc. (NYSEMKT:XXII) Engages Orion To Manufacture Nicotine-Free Cigarettes In Europe

Boston, MA 05/29/2014 (wallstreetpr) – During early morning today, 22nd Century Group Inc. (NYSEMKT:XXII) announced that its wholly-owned holding company, Goodrich Tobacco Company LLC, has entered into an  agreement with Poland based Orion, which is also a cigarette manufacturer. The letter of intent exchanged between the two companies is with respect to 22nd Century’s plan […]

Wall Street Diary: Quicksilver Resources Inc (NYSE:KWK), 22nd Century Group Inc (NYSEMKT:XXII), Diamondback Energy Inc (NASDAQ:FANG)

Boston, MA 03/28/2014 (wallstreetpr) – In order to extinguish its debts and refocus on core activities, Quicksilver Resources Inc (NYSE:KWK) which is an independent player in the oil and gas acquisition, explorations and production business, is letting go some of its joint properties. The company early this month agreed with its partner SWEPI, a wholly-owned […]

Shareholder Breakfast: IsoRay, Inc. (NYSEMKT:ISR), 22nd Century Group Inc (NYSEMKT:XXII), Keryx Biopharmaceuticals (NASDAQ:KERX)

Boston, MA 03/27/2014 (wallstreetpr) – IsoRay, Inc. (NYSEMKT:ISR) edged up Wednesday, managing to recover from the Friday fall occasioned by announced shares dilution. The stock jumped 12.62 percent to settle at $2.32. In order to raise funds for working capital and corporate purposes, the company announced that it was offering common stock shares directly to […]

Big Gainers: BG Medicine, Inc. (NASDAQ:BGMD), Galectin Therapeutics Inc. (NASDAQ:GALT), 22nd Century Group Inc (NYSEMKT:XXII)

Boston, MA 03/25/2014 (wallstreetpr) – BG Medicine, Inc. (NASDAQ:BGMD) shares are up to a new 52-week high in the current session. The shares were up almost 26 percent by 11:30 a.m. EDT. The gain in the stock can be linked to the bullish rating which analysts at Ladenburg Thalmann issued on the stock. The analysts hoisted […]

22nd Century Group Inc (NYSEMKT:XXII) Creates A Buying Chance

Boston, MA 03/24/2014 (wallstreetpr) – Share of 22nd Century Group Inc (NYSEMKT:XXII) are currently trading down. When a stock takes a downturn it scares many investors, but XXII is a different case, the fall in the stock price is seen by analysts as a perfect opportunity to buy as things are poised to get better from […]